Brief: IGM Biosciences Q1 Net Income USD -49.816 Million
08/05/2024 21:10
May 08 (Reuters) - IGM Biosciences Q1 pretax profit USD -49.816 million. * Q1 operating expenses USD 54.353 million * Q1 collaboration revenue USD 497 thousand * Q1 basic EPS USD -0.83 * Q1 operating income USD -53.856 million
Recent news on IGM Biosciences
See all newsU.S. STOCKS ON THE MOVE-Energy stocks, Apple, Vertex
U.S. STOCKS ON THE MOVE-Snap, Solventum, GlobalFoundries
IGM Biosciences rises on buyout deal with Concentra Biosciences
Brief: Igm Biosciences Enters Into Agreement To Be Acquired By Concentra Biosciences For $1.247 In Cash Per Share Plus A Contingent Value Right
IGM Biosciences Inc reports results for the quarter ended March 31 - Earnings Summary